{"id":8196,"date":"2025-11-07T23:02:24","date_gmt":"2025-11-07T23:02:24","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/11\/07\/fda-searches-for-cder-director-to-replace-george-tidmarsh\/"},"modified":"2025-11-07T23:02:24","modified_gmt":"2025-11-07T23:02:24","slug":"fda-searches-for-cder-director-to-replace-george-tidmarsh","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/11\/07\/fda-searches-for-cder-director-to-replace-george-tidmarsh\/","title":{"rendered":"STAT+: FDA broadens search for new top drug regulator after early setbacks\u00a0"},"content":{"rendered":"

STAT+: FDA broadens search for new top drug regulator after early setbacks\u00a0
\n \t

\n
<\/BR>
\n
\n \t

\n
<\/BR><\/p>\n

\n

WASHINGTON \u2014\u00a0The Food and Drug Administration is struggling to select a new head of its drug center after the sudden and chaotic exit<\/a> of the previous director, George Tidmarsh.\u00a0<\/p>\n

Richard Pazdur, the director of the FDA\u2019s Oncology Center for Excellence, was approached about the job and <\/strong>turned it down, two sources told STAT. The Pink Sheet first reported<\/a> the news, and reported<\/a> that Mary Thanh Hai, director of the Office of New Drugs, is uninterested in taking on the role. Pazdur and Thanh Hai did not respond to requests for comment.\u00a0<\/p>\n

On Friday, Deputy FDA Commissioner Sara Brenner sent an email opening the position up to employees within the agency\u2019s Center for Drug Evaluation and Research.<\/p>\n

Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n

\t

\n
<\/BR>
\n Lizzy Lawrence
\n \t

\n
<\/BR>
\nGo to statnews<\/a>
\n \t

\n
<\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"

STAT+: FDA broadens search for new top drug regulator after early setbacks\u00a0 WASHINGTON \u2014\u00a0The Food and Drug Administration is struggling to select a new head of its drug center after the sudden and chaotic exit of the previous director, George Tidmarsh.\u00a0 Richard Pazdur, the director of the FDA\u2019s Oncology Center for Excellence, was approached about […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2181,2146,2176,2155,2151,2144,2152],"tags":[2150],"class_list":["post-8196","post","type-post","status-publish","format-standard","hentry","category-exclusive","category-fda","category-pharma","category-pharmaceuticals","category-policy","category-politics","category-stat","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8196"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=8196"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/8196\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=8196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=8196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=8196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}